Table 1.68
HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis,a by race, United States, 2003 and 2004 |
| Population group |
2004 |
2003 |
| Percent |
Standard error |
Percent |
Standard error |
| Total |
|
81.8 |
1.2 |
84.3 |
1.2 |
| Age |
18-44 |
83.5 |
1.4 |
85.6 |
1.4 |
| 45 and over |
78.1 |
2.4 |
81.4 |
2.3 |
| Race |
White |
79.1 |
3.0 |
81.2 |
2.8 |
| Black |
80.9 |
1.6 |
85.5 |
1.5 |
| Hispanic |
86.7 |
2.5 |
84.2 |
2.8 |
| Other |
DSU |
DSU |
78.6 |
11.4 |
| Gender |
Male |
82.6 |
1.4 |
84.3 |
1.4 |
| Female |
79.1 |
2.7 |
84.5 |
2.4 |
| Health insurance |
Private |
75.8 |
5.5 |
85.0 |
4.6 |
| Medicaid/dual eligible |
83.0 |
1.9 |
86.8 |
1.7 |
| Medicare |
79.0 |
2.9 |
82.7 |
3.4 |
| Other/uninsured |
86.3 |
2.3 |
86.8 |
2.8 |
a For HIV patients having at least 2 CD4 tests <50 during the year.
DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: MAC: Mycobacterium avium complex.
Source: HIV Research Network.
540 Gaither Road Rockville, MD 20850